Gastrointestinal Infection Testing Market 2022
The global Gastrointestinal Infection Testing Market is on the verge of witnessing a drastic In Upcoming Years. The digital renaissance is dictating the terms for the industry. AI-powered data core is being used for delivering insights. Also, the virtual workforce is being developed with a transfer of digital skills, that too, from a plethora of innovative ecosystems and industries. Conversational AI is being deployed for helping the end-users with timely feedback. This trend is bound to take the overall industry at a greater stride in the upcoming period.
Persistence Market Research’s (PMR) recent report says that the global gastrointestinal infection testing market is expected to hit US$ 490.2 Mn by 2026. The gastrointestinal infection testing market is expected to have a CAGR of 4.9% during the forecast period of 2022-2026, according to the report.
Get Free Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/17314
According to the NCBI (National Center for Biotechnology Information), around 200 million GI illnesses occur in the United States each year. Gastrointestinal infection testing is performed to detect bacteria, viruses, and parasites. The growing frequency of gastrointestinal illnesses is increasing the number of Gastrointestinal Infection Testing, which will drive the growth of the gastrointestinal infection testing market over the forecast period.
Company Profiles:
- Becton, Dickinson and Company (BD)
- Thermo Fisher Scientific Inc.
- Bio-Rad Laboratories Inc.
- Luminex Corporation
- Hoffmann-La Roche Ltd.
- bioMérieux SA
- Quidel Corporation
- Illumina, Inc.
- Seegene Inc
- Genetic Signatures
Request for Methodology@ https://www.persistencemarketresearch.com/methodology/17314
The Asia Pacific Region, Excluding China, will have the Highest Growth Rate
The Asia Pacific region, excluding China, is projected to have the highest growth rate because of a rising patient pool due to unhealthy lifestyles and inadequate sanitation facilities.
Apart from the Asia-Pacific region, the gastrointestinal infection testing market in North America is also expected to contribute to the global gastrointestinal infection testing market’s growth due to the rising healthcare budget and initiatives to increase awareness and availability of quality gastrointestinal infection testing options in the region. However, the US FDA’s stringent rules and regulations may impede the growth of the gastrointestinal infection testing market in this region.
The Impact of COVID-19 on the Global Gastrointestinal Infection Testing Market
In 2020, as COVID-19 cases began to peak, there was a decrease in the number of gastrointestinal infection testing due to Covid-19 restrictions and lockdowns. However, in 2021, when the Covid-19 restrictions were relaxed, the Gastrointestinal Infection Testing frequency began to rise.
Access Full Report@ https://www.persistencemarketresearch.com/checkout/17314
Want More Insights?
PMR has presented a comprehensive report based on Gastrointestinal Infection Testing Market as per Product Type (Reagent Kits, Sequencing Kits, and Equipment), Disease Strains (Bacterial Strains, Viral Strains and Parasitic Strains), End User (Hospitals, Clinics/Medical Centers, Diagnostic Laboratories and Research Institutes), based on seven regions.
About Us:
Persistence Market Research (PMR), as a 3rd-party research organization, does operate through an exclusive amalgamation of market research and data analytics for helping businesses ride high, irrespective of the turbulence faced on the account of financial/natural crunches.
Contact Us:
Persistence Market Research
Address – 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com